|
|
Volumn 10, Issue 5, 2010, Pages 323-325
|
|
Loss and preservation of β-cell function: Two treatment regimes targeting T or B lymphocytes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
C PEPTIDE;
CYCLOSPORIN;
DACLIZUMAB;
HEMOGLOBIN A1C;
INSULIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PLACEBO;
RITUXIMAB;
B LYMPHOCYTE;
CD19+ B LYMPHOCYTE;
CD4+ CD25+ T LYMPHOCYTE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG FEVER;
GASTROINTESTINAL SYMPTOM;
GLYCEMIC CONTROL;
HUMAN;
HYPOTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RELEASE;
LEUKOPENIA;
MEMORY T LYMPHOCYTE;
MULTIPLE SCLEROSIS;
NAUSEA;
NEUTROPENIA;
NONHUMAN;
NOTE;
PANCREAS ISLET BETA CELL;
PRURITUS;
REGULATORY T LYMPHOCYTE;
RHEUMATOID ARTHRITIS;
UVEITIS;
|
|
EID: 77956264652
PISSN: 15344827
EISSN: None
Source Type: Journal
DOI: 10.1007/s11892-010-0141-3 Document Type: Note |
|
Times cited : (1)
|
|
References (4)
|
